LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
For 30 tablets
Pharmacies pay
$1.08 filed
30 × $0.03612 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$2.78 filed
30 × $0.09251 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.6× estimated
Medicare paid 2.6× what pharmacies pay.
Part D averages every strength and form sold under “Lisinopril-Hydrochlorothiazide” / “Lisinopril/Hydrochlorothiazide” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.24 estimated
$1.08 + $0.16 (15%) + $5.00 fee per fill = $6.24
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “lisinopril and hydrochlorothiazide” and “lisinopril and hydrochlorothiazide tablets”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Solco Healthcare LLC and Lupin Pharmaceuticals, Inc.
FDA lists it under 2 Established Pharmacologic Classes: Angiotensin Converting Enzyme Inhibitor and Thiazide Diuretic.
The NADAC file of 2026-10-14 prices it under 14 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1.08 for 30 tablets (30 × $0.03612 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 6 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Exelan Pharmaceuticals, Inc. | 4 | $0.03612 per EA filed |
| Lupin Pharmaceuticals, Inc. | 3 | $0.03612 per EA filed |
| Actavis Pharma, Inc. | 2 | $0.03612 per EA filed |
| Cipla USA Inc. | 2 | $0.03612 per EA filed |
| Solco Healthcare LLC | 2 | $0.03612 per EA filed |
| Legacy Pharmaceutical Packaging, LLC | 1 | $0.03612 per EA filed |
All 14 NDCs, with labeler and price
- 00591-0861-01 · Actavis Pharma, Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 00591-0861-05 · Actavis Pharma, Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 43547-0421-10 · Solco Healthcare LLC · $0.03612 per EA · eff. 2026-09-23 filed
- 43547-0421-50 · Solco Healthcare LLC · $0.03612 per EA · eff. 2026-09-23 filed
- 68180-0519-01 · Lupin Pharmaceuticals, Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 68180-0519-02 · Lupin Pharmaceuticals, Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 68180-0519-30 · Lupin Pharmaceuticals, Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 68645-0557-54 · Legacy Pharmaceutical Packaging, LLC · $0.03612 per EA · eff. 2026-09-23 filed
- 69097-0969-07 · Cipla USA Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 69097-0969-12 · Cipla USA Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 76282-0447-01 · Exelan Pharmaceuticals, Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 76282-0447-05 · Exelan Pharmaceuticals, Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 76282-0447-10 · Exelan Pharmaceuticals, Inc. · $0.03612 per EA · eff. 2026-09-23 filed
- 76282-0447-90 · Exelan Pharmaceuticals, Inc. · $0.03612 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
2 other products in the NADAC file share an FDA nonproprietary name with LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB | $0.02934 per EA filed | $0.09251 per EA filed |
| LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB this page | $0.03612 per EA filed | $0.09251 per EA filed |
| LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB | $0.04084 per EA filed | $0.09251 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 14 NDCs’ NADAC prices is $0.03612 per EA filed.
Of the 50 other products in FDA’s Angiotensin Converting Enzyme Inhibitor class priced per EA, 45 have a higher middle NADAC price and 5 a lower one. The one in the middle is AMLODIPINE-BENAZEPRIL 5-40 MG, at $0.14392 per EA filed (eff. 2026-09-23).
Of the 68 other products in FDA’s Thiazide Diuretic class priced per EA, 63 have a higher middle NADAC price and 5 a lower one. The one in the middle is AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB, at $0.44985 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $2.78 for 30 tablets, at an average of $0.09251 per EA in 2024 (2024-01-01 to 2024-12-31) for “Lisinopril-Hydrochlorothiazide” and “Lisinopril/Hydrochlorothiazide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 5,642,341 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Lisinopril-Hydrochlorothiazide / Lisinopril/Hydrochlorothiazide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic classes
Related in the same class
- BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB
- ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET
- FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB
- LISINOPRIL 10 MG TABLET
- HYDROCHLOROTHIAZIDE 12.5 MG TB